Members |
targetComponentId |
Cholestyramine+aspartame 4g/sachet powder |
Colestyramine 4 g powder for oral suspension sachet |
Choline salicylate 870mg/5ml liquid |
Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug) |
Choline salicylate+glycerol 20%/12.6% ear drops |
Product containing precisely choline 200 milligram/1 milliliter and glycerol 126 milligram/1 milliliter conventional release ear solution (clinical drug) |
allergie au théophyllinate de choline |
Allergy to theophylline (finding) |
Chondrocalcinosis due to dicalcium phosphate crystals, NOS |
Chondrocalcinosis due to dicalcium phosphate crystals |
Chondrocalcinosis due to dicalcium phosphate crystals, of other specified site |
Chondrocalcinosis due to dicalcium phosphate crystals |
Chondrocalcinosis due to dicalcium phosphate crystals, of unspecified site |
Chondrocalcinosis due to dicalcium phosphate crystals |
chondrocyte |
Chondrocyte (substance) |
Chondrosarcoma - category |
Chondrosarcoma |
Chondrosarcoma, no International Classification of Diseases for Oncology subtype |
Chondrosarcoma |
Choriocarcinoma, no International Classification of Diseases for Oncology subtype |
Choriocarcinoma (morphologic abnormality) |
choriogonadotropine alfa 10 000 UI, ampoule de poudre et solvant pour solution injectable |
Choriogonadotropin alfa only product in parenteral dose form |
Choriogonadotropin alfa 10,000iu powder for conventional release solution for injection ampule |
Choriogonadotropin alfa only product in parenteral dose form |
choriogonadotropine alfa 1500 UI, ampoule de poudre et solvant pour solution injectable |
Choriogonadotropin alfa only product in parenteral dose form |
Choriogonadotropin alfa 1500iu powder for conventional release solution for injection ampule |
Choriogonadotropin alfa only product in parenteral dose form |
choriogonadotropine alfa 2000 UI, ampoule de poudre et solvant pour solution injectable |
Choriogonadotropin alfa only product in parenteral dose form |
Choriogonadotropin alfa 2000iu powder for conventional release solution for injection ampule |
Choriogonadotropin alfa only product in parenteral dose form |
choriogonadotropine alfa 5000 UI, ampoule de poudre et solvant pour solution injectable |
Product containing only choriogonadotropin (medicinal product) |
Choriogonadotropin alfa 5000iu powder for conventional release solution for injection ampule |
Product containing only choriogonadotropin (medicinal product) |
Choroid meningioma |
Meningioma, chordoid (morphologic abnormality) |
Choroid plexus papilloma, no International Classification of Diseases for Oncology subtype |
Benign choroid plexus papilloma (morphologic abnormality) |
Choroideremia co-occurrent with hypopituitarism |
Choroideremia with deafness and obesity syndrome (disorder) |
Chromic phosphate, p-32 15mCi injection suspension 10mL vial |
Chromic phosphate (32-P) only product in parenteral dose form |
Chromic phosphate, p-32 7.0mil/mL injection |
Chromic phosphate (32-P) only product in parenteral dose form |
Chromic phosphate[32P] 185MBq/mL injection |
Chromic phosphate (32-P) only product in parenteral dose form |
Chromic phosphate[32P] 185MBq/mL powder for injection solution vial |
Chromic phosphate (32-P) only product in parenteral dose form |
Chromobacterium fluviatile |
Iodobacter fluviatilis |
Chromobacterium lividum |
Janthinobacterium lividum (organism) |
Chromosome replaced with ring or dicentric |
Ring chromosome |
Chronic active type A viral hepatitis |
Viral hepatitis, type A |
Chronic aggressive type A viral hepatitis |
Viral hepatitis, type A |
Chronic angle-closure glaucoma |
Chronic angle-closure glaucoma |
Chronic antritis |
Chronic maxillary sinusitis |
Chronic cyclitis |
Intermediate uveitis |
Chronic erythremia |
Polycythemia vera (clinical) |
Chronic erythremia |
Polycythemia vera |
Chronic erythremia |
Polycythemia vera (clinical) |
Chronic erythremia in remission |
Polycythemia vera (clinical) |
Chronic female pelvic peritonitis |
Chronic inflammation of pelvic peritoneum (disorder) |
Chronic infection |
Chronic infectious disease |
Chronic iridocyclitis due to another disorder |
Iridocyclitis |
Chronic kidney disease clinical management plan |
Chronic kidney disease clinical management plan (record artifact) |
Chronic leukemia - category |
Chronic leukemia (morphologic abnormality) |
Chronic lymphoid leukemia - category |
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma |
Chronic lymphoproliferative disease |
Lymphoproliferation of uncertain behavior (morphologic abnormality) |
Chronic monocytic leukemia |
Myeloid leukaemia |
Chronic monocytic leukemia |
Chronic myelomonocytic leukaemia |
Chronic monocytic leukemia in remission |
Myeloid leukemia in remission |
Chronic multifocal osteomyelitis |
Chronic nonbacterial osteomyelitis/chronic recurrent multifocal osteomyelitis |
Chronic multifocal osteomyelitis |
Chronic nonbacterial osteomyelitis/chronic recurrent multifocal osteomyelitis |
Chronic myelogenous leukemia, BCR/ABL positive |
Chronic myeloid leukemia (morphologic abnormality) |
Chronic myelogenous leukemia, no International Classification of Diseases for Oncology subtype |
Chronic myeloid leukemia (morphologic abnormality) |
Chronic myeloid leukemia - category |
Chronic myeloid leukemia (morphologic abnormality) |
Chronic myelomonocytic leukemia |
Chronic myelomonocytic leukaemia |
Chronic myeloproliferative disease, no International Classification of Diseases for Oncology subtype |
Malignant myeloproliferative neoplasm (morphologic abnormality) |
Chronic myeloproliferative disorder |
Malignant myeloproliferative neoplasm (morphologic abnormality) |
Chronic necrotizing pulmonary aspergillosis |
Subacute invasive pulmonary aspergillosis (disorder) |
Chronic neurogenic ulcer of skin |
Neurogenic ulcer |
Chronic non-A non-B hepatitis |
Chronic viral hepatitis |
Chronic nonspecific lung disease |
Chronic lung disease (disorder) |
Chronic obstructive airway disease with asthma |
Asthma-chronic obstructive pulmonary disease overlap syndrome |
Chronic obstructive pulmonary disease clinical management plan |
Chronic obstructive pulmonary disease clinical management plan (record artifact) |
Chronic osteomyelitis of other specific site, NEC |
Chronic osteomyelitis |
Chronic persistent type A viral hepatitis |
Viral hepatitis, type A |
Chronic polyarticular juvenile rheumatoid arthritis |
Polyarticular juvenile idiopathic arthritis |
Chronic postrheumatic arthropathy |
Jaccoud's syndrome |
Chronic pyelonephritis |
Chronic pyelonephritis |
Chronic secretory otitis media |
Chronic mucoid otitis media |
Chronic trophic ulcer of other specified site |
Chronic trophic ulcer of skin |
Chronic type A viral hepatitis |
Viral hepatitis, type A |
Chronic ulcer of other specified site |
Chronic ulcer of skin (disorder) |
Chronic uremia |
Chronic renal failure |
Chronic yellow atrophy of liver |
Chronic necrosis of liver |
Chronobiologic disorder |
Abnormal chronobiologic state (finding) |
Chryseobacterium meningosepticum |
Elizabethkingia meningoseptica (organism) |
Chryseobacterium miricola |
Elizabethkingia miricola (organism) |
Chryseobacterium scopthalmum |
Chryseobacterium scophthalmum (organism) |
Chryseomonas species |
Pseudomonas |
Chudley Lowry Hoar syndrome |
Alpha thalassemia X-linked intellectual disability syndrome (disorder) |
Chymopapain extract |
Product containing chymopapain (medicinal product) |
Ciclesonide 160micrograms inhaler |
Product containing only ciclesonide in pulmonary dose form (medicinal product form) |
Ciclesonide 80micrograms inhaler |
Product containing only ciclesonide in pulmonary dose form (medicinal product form) |
Ciclopirox 0.77% topical suspension |
Product containing precisely ciclopirox (as ciclopirox olamine) 7.7 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Ciclopirox olamine 8% solution |
Product containing precisely ciclopirox 80 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
cidofovir 75 mg/mL, fiole de 5 mL de concentré pour perfusion |
Cidofovir 75 mg/mL solution for injection |
Cidofovir 75mg/mL injection |
Cidofovir 75 mg/mL solution for injection |
Cidofovir 75mg/mL injection solution 5mL vial |
Cidofovir 75 mg/mL solution for injection |
Cigarette cough |
Smokers' cough |
Ciguatera |
Ciguatoxin causing toxic effect |
Cilazapril allergy |
Non-allergic hypersensitivity to cilazapril (finding) |
Cilioretinal artery sparing |
Cilioretinal artery sparing (finding) |
Cimetidine hydrochloride 300mg/50 mL injection |
Product containing precisely cimetidine 6 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Cimetidine hydrochloride 300mg/50mL(0.9%) conventional release solution for infusion 50mL bag |
Product containing precisely cimetidine 6 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Cimetidine hydrochloride 300mg/50mL(0.9%) intravenous solution 50mL bag |
Product containing precisely cimetidine 6 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Ciprofloxacin 0.2% + hydrocortisone 1% otic solution |
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) |
Ciprofloxacin 1000mg m/r tablet |
Ciprofloxacin only product in oral dose form |
Ciprofloxacin 1000mg prolonged-release oral tablet |
Ciprofloxacin only product in oral dose form |
Ciprofloxacin 10g/100mL oral suspension |
Ciprofloxacin 100 mg/mL oral suspension |
Ciprofloxacin 200mg solution |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
Ciprofloxacin 200mg/100mL |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
Ciprofloxacin 200mg/100mL intravenous injection solution 100mL premixed bag |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |